Some new details emerging from the Biogenesis story. ESPN’s T.J. Quinn and Mike Fish spoke to a source who claims that Alex Rodriguez got special treatment from the Biogenesis clinic. Owner Anthony Bosch, Quinn and Fish’s source says, would personally go to A-Rod’s Miami home and inject him with HGH.
Bosch and A-Rod have denied everything related to the reports of these past few days, of course. It’s also worth noting that Quinn and Fish’s source tells of a time last year when A-Rod allegedly got mad at Bosch after Bosch “had trouble locating a vein,” despite the fact that HGH injections are not intravenous (Quinn and Fish note this disconnect).
Also of note, no one down in Miami can confirm that the DEA has opened an investigation at all and there is no evidence of an ongoing investigation. It’s possible that the DEA is just playing it cool and operating with unusual stealthiness. It’s also possible that, while this is a big story for baseball, the DEA in Miami (or all places) has bigger fish to fry than a now-closed anti-aging clinic.
That part is of some significance. For only the government has subpoena power here. Bud Selig does not. And if the government is not involved in this, or is not moving particularly quickly, Major League Baseball is unlikely to have more at its disposal than (a) a newspaper report; (b) copies of uncorroborated medical records; and (c) the denials of all the players involved.
If so, could they even suspend these guys on a “just cause” basis pursuant to the Joint Drug Agreement?
Update (8:51 PM EST): The deal is in place, according to Heyman.
Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.
Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.
Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.
Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.
Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.
Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.
Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.
Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.
Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.